Traders Sell UnitedHealth Group Incorporated (UNH) on Strength Following Insider Selling
Traders sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading on Thursday following insider selling activity. $81.70 million flowed into the stock on the tick-up and $116.96 million flowed out of the stock on the tick-down, for a money net flow of $35.26 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $1.27 for the day and closed at $211.13Specifically, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the sale, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders sold a total of 72,606 shares of company stock worth $14,308,783 in the last three months. Company insiders own 0.89% of the company’s stock.
A number of analysts recently issued reports on UNH shares. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley lifted their target price on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $216.65.
The firm has a market capitalization of $204,130.00, a price-to-earnings ratio of 22.05, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.
A number of institutional investors and hedge funds have recently modified their holdings of UNH. Ameriprise Financial Inc. boosted its position in shares of UnitedHealth Group by 29.9% during the 1st quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock worth $546,574,000 after purchasing an additional 766,573 shares in the last quarter. Gerber Kawasaki Wealth & Investment Management bought a new position in shares of UnitedHealth Group during the 1st quarter worth about $227,000. Patriot Financial Group Insurance Agency LLC boosted its position in shares of UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after purchasing an additional 603 shares in the last quarter. Toronto Dominion Bank boosted its position in shares of UnitedHealth Group by 43.8% during the 1st quarter. Toronto Dominion Bank now owns 299,729 shares of the healthcare conglomerate’s stock worth $49,171,000 after purchasing an additional 91,262 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its position in UnitedHealth Group by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after acquiring an additional 12 shares in the last quarter. 86.00% of the stock is currently owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.